Meesho Faces Legal Scrutiny Over Fatal Pesticide Sale in 2026
In 2026, Gurugram Police registered an FIR against Meesho and a Surat-based seller for allegedly selling a restricted pesticide that led to a minor's death. This case highlights the regulatory scrutiny on ecommerce platforms.
LazyFounders

30 SEC SUMMARY:
- Gurugram Police filed an FIR against Meesho and a Surat-based seller for selling a restricted pesticide that led to a minor's death.
- The case highlights the regulatory scrutiny on ecommerce platforms for listing and selling potentially lethal substances.
- The investigation focuses on the online transaction and the roles of Meesho and the seller.
TABLE OF CONTENTS:
1. Introduction
2. The Incident
3. Legal Actions
4. Previous Legal Issues
5. Meesho's Profile
6. Key Highlights
7. FAQ
8. Conclusion
9. Call-to-Action
KEY HIGHLIGHTS:
- FIR registered against Meesho and a Surat-based seller.
- Investigation into the sale of restricted pesticide that led to a minor's death.
- Previous legal issues involving Meesho in 2021 and 2022.
Introduction
In 2026, Gurugram Police registered an FIR against the Indian ecommerce platform, Meesho, and a Surat-based seller following the tragic death of a 17-year-old who allegedly ordered a restricted pesticide through the platform.
The Incident
The incident came to light when Anuradha Mehra, the mother of the deceased, discovered her son's order for the pesticide on his mobile phone after his death. The minor had consumed the substance on April 28 and died shortly after. The police found that the pesticide was ordered through the Meesho app on April 11. The seller was identified as Pankaj Bharatbhai Parmar, the operator of Evergreen Agro and Gardening Mall.
Legal Actions
Mehra approached a court alleging that regulations governing the sale of the substance had been violated. On the court's direction, an FIR was registered at the Badshahpur police station on August 19 under Sections 106 and 286 of the BNS. These provisions pertain to causing death by negligence and negligent conduct involving poisonous substances, respectively.
Previous Legal Issues
This is not the first time Meesho has faced legal scrutiny. In 2022, the Maharashtra FDA filed an FIR against the platform for allegedly selling MTP kits without prescriptions or pharmacy bills. Additionally, in 2021, an FIR was registered against Meesho's founders over allegations of selling counterfeit luxury goods. Separately, the Delhi High Court sought the Centre’s response to a petition alleging that Meesho and other ecommerce platforms were not complying with certain product disclosure requirements.
Meesho's Profile
Headquarter City: Bengaluru Founders: Sanjeev Barnwal +1 Total Funding Amount: $1.6 Bn
Key Highlights
- FIR registered against Meesho and a Surat-based seller.
- Investigation into the sale of restricted pesticide that led to a minor's death.
- Previous legal issues involving Meesho in 2021 and 2022.
FAQ
**Q1: What is the nature of the pesticide involved in the incident? A1: The pesticide involved is referred to as 'Sulfas'.
**Q2: What actions are being taken by the police? A2: The police are investigating the online sale of Sulfas, the ordering process, and the role of the seller.
**Q3: What previous legal issues has Meesho faced? A3: Meesho faced legal scrutiny in 2022 for selling MTP kits without prescriptions and in 2021 for selling counterfeit luxury goods.
Conclusion
The case against Meesho and the Surat-based seller underscores the critical need for stringent regulatory oversight on ecommerce platforms to prevent the sale of potentially lethal substances.
Call-to-Action
For more insights on ecommerce platforms, visit blogy.in.
Sources
- inc42.com · 2026-08-21
Meesho Faces FIR Over Alleged Sale Of Toxic ‘Sulfas’ Linked To Minor’s Death
This story is an original summary and analysis written by LazyFounders from the reporting listed above. Facts are attributed to their original publishers; sections marked as analysis are LazyFounders's opinion. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links.


